Overfeeding disrupts the hypothalamic response to glucose ingestion in healthy men.
ID
Bron
Verkorte titel
Aandoening
diabetes type 2
suikerziekte
ouderdomssuikerziekte
diabetes
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
1. FMRI scans of hypothalamus;<br>
2. Polysomnography/MSLT.
Achtergrond van het onderzoek
It has long been recognized that the hypothalamus plays a crucial role in metabolism. It is thought that the hypothalamus and brain stem get input from the periphery about the available food sources and that, thereafter, efferent neuroendocrine systems come in action to regulate food intake.
Several groups have focused on the effect of glucose ingestion on blood oxygen level-dependent (BOLD) signals in the hypothalamus (detected by MRI). Although there have been some contradicting papers, most studies found that the BOLD signal is diminished after the ingestion of glucose.
In 1999 Matsuda et al. looked at the effect of glucose ingestion in obese people on BOLD signals in the hypothalamus. The results were compared to healthy controls. It was found that the hypothalamic (paraventricular and ventromedial nuclei) BOLD signal decreases significantly in healthy people compared to obese people.
Similarly, in healthy individuals the BOLD signal diminishes after the ingestion of a glucose load. In diabetic patients however, the BOLD signal does not decline. This suggests that the hypothalamic response in these patients is altered – which could mean that metabolic and endocrine cues about the metabolic state are erroneously interpreted in diabetic patients.
Therefore, in this study we will evaluate the hypothesis that overfeeding disrupts the hypothalamic response to glucose ingestion in healthy men.
Doel van het onderzoek
Overfeeding disrupts the hypothalamic response to glucose ingestion in healthy men.
Onderzoeksopzet
28-02-2009 start of study.
Onderzoeksproduct en/of interventie
High caloric diet during 6 days.
Publiek
Leiden University Medical Center
Dept of Endocrinology and Metabolism, C4-67
Albinusdreef 2
Leiden 2333 ZA
The Netherlands
+31715265304
m.a.wijngaarden@lumc.nl
Wetenschappelijk
Leiden University Medical Center
Dept of Endocrinology and Metabolism, C4-67
Albinusdreef 2
Leiden 2333 ZA
The Netherlands
+31715265304
m.a.wijngaarden@lumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Healthy males;
2. Healthy diet;
3. Age 19-29;
4. BMI 19-25 kg/m2;
5. Stable weight for the last 2 years;
6. Caucasian;
7. FPG < 6 mmol/L;
8. Hb > 7.5 mmol/l;
9. No family history of DM2.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Use of medication known to affect glucose metabolism (for example prednisone) or lipid metabolism;
2. History of genetic or psychiatric disease (e.g. fragile X syndrome, major depression) that affects the brain;
3. Significant chronic disease;
4. Renal or hepatic disease;
5. Recent weight changes or attempts to loose or gain weight (> 3 kg weight gain or loss, within the last 3 months);
6. Smoking (current);
7. Alcohol consumption of more than 28 units per week at present or in the past;
8. Recent blood donation (within the last 3 months);
9. Recent participation in other research projects (within the last 3 months);
10. Participation in 2 or more projects in one year;
11. Sleep disorders;
12. Contra-indication to MRI scanning:
A. Claustrophobia;
B. Pacemakers and defibrillators;
C. Nerve stimulators;
D. Intracranial clips;
E. Intraorbital or intraocular metallic fragments;
F. Cochlear implants;
E. Ferromagnetic implants.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL1642 |
NTR-old | NTR1740 |
Ander register | METC LUMC : P08.195 |
ISRCTN | ISRCTN wordt niet meer aangevraagd |